'Bisphosphonates' diaporamas de présentation

Pharmacologic Options for Osteoporosis Prevention and Treatment Alireza Khabbazi, MD

Pharmacologic Options for Osteoporosis Prevention and Treatment Alireza Khabbazi, MD. BONE PHYSIOLOGY. Most common bone disease in humans Characterized by: Low bone mass Microarchitectural deterioration Compromised bone strength Increased risk for fracture. BONE PHYSIOLOGY.

997 views • 75 slides

Osteoporosis Treatment in Frail Populations: A Framework for Decision-Making

451 views • 38 slides

Alendronate

589 views • 20 slides

Y27632

S1P. LPA. Edg 1,3,5,6,8. Edg 2,4,7. Cell membrane. Rho. Rho. ROCK. GTP. C3. Bisphosphonates. FAK. Y27632. GG-PP. MVA. Rho. Growth and Survival. Adhesion, Motility, Invasion. GDP. GDP. Apoptosis.

157 views • 1 slides

ncponc0688 pf3

Figure 3 Disease distribution in publications detailing bisphosphonate-related ONJ (derived from data in Table 2).

140 views • 1 slides